Similarly, treatment with AAV9-REGABA-eTFSCN1A also significantly increased resistance to HTS in an alternative mouse model of DS,11,25 where a nonsense mutation (R1407X) was introduced in the reading frame of one copy of SCN1A (Supplementary Fig. S3A). The gene discussed is SCN1A; the disease is Dravet syndrome.